MedPath

Pulmonary Effects of 100% Biodiesel Exhaust

Not Applicable
Completed
Conditions
Inflammation
Interventions
Other: Bronchoscopy
Registration Number
NCT02690571
Lead Sponsor
Umeå University
Brief Summary

Air pollution is a global environmental and health concern, contributing to onset and deterioration of respiratory and cardiovascular diseases. As climate change and dependence on diminishing fossil fuel supplies have taken center stage in political and scientific debates, renewable carbon-neutral fuels like biodiesel receive increasing attention. The most common biodiesel within the European Union, rapeseed oil methyl ester (RME) is perceived to be a "green fuel", as it is sustainable and of biological origin, and therefore is often predicted to be less harmful to human health. Whilst replacing petrodiesel with biodiesel may have advantageous ecological impacts, consequences to respiratory health remained largely unexplored.

The purpose of the current study is to evaluate whether inhalation of 100% RME biodiesel exhaust would result in an acute airway inflammatory response in healthy human subjects, as shown previously following exposure to petrodiesel exhaust.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15
Inclusion Criteria

Normal ECG

Normal Lung function

Normal Blood samples

Exclusion Criteria

Smoking

Pre-existing metabolomic, respiratory and cardiovascular disease

Exposure to high levels of pollutants in occupation

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Filtered air exposureBronchoscopyOne hour exposure to filtered air during intermittent exercise in controlled chamber, 6 hours after exposure bronchoscopy is performed.
Biodiesel exhaust exposureBronchoscopyOne hour exposure to biodiesel exhaust (generated at same running conditions as earlier studies with diesel exhaust at approximate particle matter concentration 300 mcg/m3) during intermittent exercise in controlled chamber. Six hours after exposure bronchoscopy is performed.
Primary Outcome Measures
NameTimeMethod
Cytokines in Bronchial wash (BW)6 hours

Bronchial wash (BW) collected by bronchoscopy will be analyzed for cytokines (%).

Cell counts in Bronchial Wash6 hours

Bronchial wash (BW) collected by bronchoscopy will be analyzed for inflammatory cell counts (cells/ml).

Secondary Outcome Measures
NameTimeMethod
Oxylipin Metabolomic profilingBaseline, 2 hours, 6 hours, 24 hours

Metabolomic testing done with mass spectrometry on blood samples, BW and BAL.

Inflammation in bronchoalveolar lavage (BAL)6 hour

BAL collected by bronchoscopy will be analyzed for inflammatory markers, such as cell counts (cells/ml).

Inflammation in endomucosal biopsies6 hours

Biopsies collected by bronchoscopy will be analyzed for inflammatory markers, such as cell counts (cells/mm2).

© Copyright 2025. All Rights Reserved by MedPath